Matthew Strobeck - 20 May 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
Issuer symbol
BDSX
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
22 May 2025, 16:16:43 UTC
Previous filing
06 Nov 2024
Next filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Strobeck Matthew Director 919 WEST DILLON RD, LOUISVILLE /s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck 22 May 2025 0001377832

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +80,525 $0.000000 80,525 20 May 2025 Common Stock 80,525 Direct F1, F2, F3
transaction BDSX Stock Options (Right to Buy) Award $0 +42,010 $0.000000 42,010 20 May 2025 Common Stock 42,010 $0.2708 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
F2 These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F3 Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
F4 This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer.